Image commercially licensed from Unsplash
RNR Healthcare, a pharma trading business led by Chief Executive Officer Vicky Ramancha, is announcing that any high-demand pharma product can be provided by RNR Healthcare as RNR Healthcare works directly with leading global pharma product manufacturers.
RNR Healthcare specializes in the procurement of highly demanded pharma products. Vicky Ramancha also adds that with RNR Healthcare, clients can order any medical equipment product or pharmaceutical product, and the company will be able to source the product directly from the original source.
RNR Healthcare has access to leading pharma manufacturers in Europe, Asia, and the US. Vicky Ramancha says that there are many different pharma products in circulation right now, and each product has its own specific details, and it is possible that certain products are only manufactured in certain regions. However, “at RNR Healthcare, we make sure that our reach is the best possible reach a trading company can get in the international pharma supply chain network,” – adds Vicky Ramancha.
RNR Healthcare has a long trading history of medical products and strong relationships with the world’s leading manufacturers. Vicky Ramancha says that the business growth potential for RNR Healthcare is enormous, and as an ex-family office fund manager, Vicky Ramancha invites international investors to connect and possibly establish new business relationships with RNR Healthcare as in the private equity business within the pharmaceutical sector.
Vicky Ramancha is proud to acknowledge the success factor of RNR Healthcare being able to extend its roots to global factories and provide the best product pricing for international markets during shortage issues. RNR Healthcare has multiple business representations in the US, Middle East and Far East Asia, including a strong team management unit in China.
Ever since COVID-19, both private and public sectors have taken more aggressive measures for pharmaceutical and medical equipment sourcing and production. Additionally, after COVID-19, we have seen numerous other viruses appear and do damage in different regions around the world. It is uncertain how future diseases will develop themselves, but it is sure that in the next 5-10 years and beyond, any time a new pandemic can emerge, people are worried and getting prepared for it.
At the same time, people are now purchasing more pharmaceutical and medical equipment products than ever before. People consume more pharmaceutical products today than, say, 20 years ago. At the same time, this does cause issues to the healthcare of the human body as the human body is not supposed to consume as much medicine supplements. This raises new concerns about our well-being and health, which again raises new opportunities for Pharma companies to produce even more products to counter every single issue that arises in the market.
Vicky Ramancha says that RNR Healthcare’s positioning as a product sourcing specialist and trader enterprise is very strong, considering that the majority of RNR Healthcare’s clients are from the US, and in the US, the pharmaceutical business is very well established for mass distribution. Additionally, the Pharma culture in the US is very advanced. In other countries like Far East Asia, while the Pharma industry is advanced, a lot of people still use traditional methods for health. Unlike in the US, more people rely on developed medicines and products.
